2-((7-(3,4-Dimethoxyphenyl)quinoxalin-2-yl)amino)-N-methylacetamide, 98%, 10mg

(S)-Methyl 2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride, 95.0%, 1g

1-Bromo-4-[(iso-propyloxy)methyl]benzene, 97.0%, 100mg

1-(9H-Carbazol-2-yl)ethanone, 95.0%, 5g

3-Methylsalicylic acid, min. 98.5%, for synthesis, 100 g, glass packaging

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 100mg

3-Bromo-4-methylbenzoic acid, 98.0%, 25g

1-(4-CHLOROPHENOXY)-3,3-DIMETHYLBUTAN-2-ONE, 95.0%, 1g

5-Bromo-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 5g

N-(4-Chloro-3-hydroxyphenyl)acetamide, 95.0%, 5g

4,7-DIFLUORO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 100mg

3',4',5'-Trifluoroacetophenone, 97.0%, 5g

4-[(4-chlorobenzyl)oxy]-3-methoxybenzaldehyde, 500mg